Craniopharyngioma
Craniopharyngioma
Craniopharyngiomas account for 1% to 4.6% of all intracranial tumors. 13% of suprasellar tumors. Their incidence represents 0.5 to 2.5 new cases per 1 million population per year. They comprise 5–11% of pediatric brain tumors. Peak incidence: age 5–9 year of age range. Benign in histology, malignant in behavior due to infiltration in neural tissue can make them difficult to cure
Presentation
- Progressive dimness of vision
- Headache
- Vomiting
- Restricted growth
- Delayed onset of puberty
- Diabetes insipidus
- Obesity
- Memory impairment
- Personality change
- Erectile dysfunction (men) / Amenorrhea (in women)